Automated insulin delivery postpartum: insights from the AiDAPT study extension
- PMID: 39884301
- DOI: 10.1016/S2213-8587(24)00374-7
Automated insulin delivery postpartum: insights from the AiDAPT study extension
Conflict of interest statement
DNO has served on advisory boards to Ypsomed, Medtronic, Insulet, and Abbott; has received research support from Medtronic, Abbott, Insulet, Dexcom, and Tandem; and received honoraria and travel support from Medtronic, Abbott, and Insulet. GPR has no conflicts to declare.
Comment on
-
Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study.Lancet Diabetes Endocrinol. 2025 Mar;13(3):210-220. doi: 10.1016/S2213-8587(24)00340-1. Epub 2025 Jan 27. Lancet Diabetes Endocrinol. 2025. PMID: 39884300 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
